The trial posting for Subcutaneous continuous glucose monitoring and intravenous dosing of insulin and dextrose for automated glycemic control in the inpatient setting is not listed as active in database. The trial may have stopped recruiting.
About Type 2 Diabetes:
Type 2 diabetes is a metabolic disorder resulting from the body's inability to make enough, or to properly use, insulin. It used to be called non-insulin-dependent diabetes mellitus (NIDDM).
Without adequate production or utilization of insulin, the body cannot move blood sugar into the cells. It is a chronic disease that has no known cure. It is the most common type of diabetes, accounting for 90 to 95 percent of diabetes cases.